[
  {
    "ts": null,
    "headline": "Best Dividend Aristocrats For September 2025",
    "summary": "Discover top Dividend Aristocrats for 2025! Explore undervalued picks with 10%+ annualized returns, robust payout growth, and reliable income opportunities.",
    "url": "https://finnhub.io/api/news?id=6fa72cb3c60dde4a3180ad17c2df91d58aa59ccc934dd1f72334c03464c353e0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756303789,
      "headline": "Best Dividend Aristocrats For September 2025",
      "id": 136539374,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1962656730/image_1962656730.jpg?io=getty-c-w1536",
      "related": "NDSN",
      "source": "SeekingAlpha",
      "summary": "Discover top Dividend Aristocrats for 2025! Explore undervalued picks with 10%+ annualized returns, robust payout growth, and reliable income opportunities.",
      "url": "https://finnhub.io/api/news?id=6fa72cb3c60dde4a3180ad17c2df91d58aa59ccc934dd1f72334c03464c353e0"
    }
  },
  {
    "ts": null,
    "headline": "5 Revealing Analyst Questions From Nordson’s Q2 Earnings Call",
    "summary": "Nordson’s second quarter was marked by strong demand in its Advanced Technology Solutions and Medical and Fluid Solutions segments, which helped the company surpass Wall Street expectations for both revenue and non-GAAP earnings per share. Management credited the ongoing integration of the Atrion acquisition as a key factor in expanding the medical product portfolio, particularly in proprietary fluid delivery and cardiovascular solutions. CEO Sundaram Nagarajan pointed to operational execution a",
    "url": "https://finnhub.io/api/news?id=334d080ede384d3ad4a8600e0ec85f42649a082ab4c9b3825d3f7f154d69447c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756272677,
      "headline": "5 Revealing Analyst Questions From Nordson’s Q2 Earnings Call",
      "id": 136537198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "NDSN",
      "source": "Yahoo",
      "summary": "Nordson’s second quarter was marked by strong demand in its Advanced Technology Solutions and Medical and Fluid Solutions segments, which helped the company surpass Wall Street expectations for both revenue and non-GAAP earnings per share. Management credited the ongoing integration of the Atrion acquisition as a key factor in expanding the medical product portfolio, particularly in proprietary fluid delivery and cardiovascular solutions. CEO Sundaram Nagarajan pointed to operational execution a",
      "url": "https://finnhub.io/api/news?id=334d080ede384d3ad4a8600e0ec85f42649a082ab4c9b3825d3f7f154d69447c"
    }
  }
]